- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
NAG-NAG.2: 5 residues within 4Å:- Chain A: V.144, R.162, I.164, N.167, T.168
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 5 residues within 4Å:- Chain A: T.267, H.299, N.301, T.383, R.412
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 2 residues within 4Å:- Chain C: V.144, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 5 residues within 4Å:- Chain C: T.267, H.299, N.301, T.383, R.412
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 5 residues within 4Å:- Chain C: R.278
- Chain E: V.144, R.162, I.164, N.167
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 5 residues within 4Å:- Chain E: T.267, H.299, N.301, T.383, R.412
No protein-ligand interaction detected (PLIP)- 48 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 3 residues within 4Å:- Chain A: N.204, T.206, S.244
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain A: N.246, T.248
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain A: N.308, W.364
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain A: N.324
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain A: N.332, S.333, T.341
- Ligands: NAG.15, NAG.16
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: T.342, N.355
- Ligands: NAG.14
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: S.357, N.361
- Ligands: NAG.14
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.1
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain A: V.104, N.106, N.118, S.120, D.290
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: Q.100, S.120, N.122
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain A: Q.263, N.265, N.301, S.303, R.412
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.271, I.292, V.410
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: E.57, N.58
- Chain B: S.17
- Chain I: Y.107
Ligand excluded by PLIPNAG.23: 10 residues within 4Å:- Chain B: N.100, S.102, W.103
- Chain F: A.1, V.2, I.4, G.5
- Chain G: Y.33, Y.103
- Chain H: W.94
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: N.107, S.109
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain B: E.123, N.126, Y.127
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: N.204, T.206, S.244
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.246, T.248, N.249
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain C: N.308, W.364
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain C: N.324
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain C: N.332, S.333, S.357
- Ligands: NAG.31, NAG.32
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain C: N.355, S.357
- Ligands: NAG.30
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: N.361
- Ligands: NAG.30
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain C: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.4
Ligand excluded by PLIPNAG.34: 5 residues within 4Å:- Chain C: V.104, N.118, S.120, Y.135, D.290
Ligand excluded by PLIPNAG.35: 6 residues within 4Å:- Chain C: T.98, Q.100, S.120, F.121, N.122, K.133
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain C: Q.263, N.265, N.301, S.303, R.412
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: N.271, Q.408, V.410
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain C: E.57, N.58
- Chain D: G.16, S.17
- Chain K: Y.107
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain D: N.100, S.102, L.134
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: E.2
- Chain D: N.107
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain D: E.123, N.126, Y.127
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain E: N.204, T.206, S.244
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain E: N.246, N.249
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain E: N.308, S.362, W.364
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain E: N.324
Ligand excluded by PLIPNAG.46: 7 residues within 4Å:- Chain E: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG.47, NAG.48
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain E: N.355, S.357, R.387
- Ligands: NAG.46
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain E: N.361
- Ligands: NAG.46
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain E: P.261, N.416
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.7
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain E: N.106, N.118, Y.135, D.290
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain C: D.129
- Chain E: T.98, Q.100, S.120, N.122
Ligand excluded by PLIPNAG.52: 7 residues within 4Å:- Chain E: N.265, N.301, V.302, S.303, S.381, R.412, V.414
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain E: N.271
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain E: E.57, N.58
- Chain F: S.17
Ligand excluded by PLIPNAG.55: 9 residues within 4Å:- Chain D: A.1, V.2, G.3, I.4
- Chain F: N.100, S.102
- Chain K: I.101, Y.103
- Chain L: W.94
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain F: N.107, L.108, S.109
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain F: E.123, N.126, Y.127
- Chain K: G.55, K.57
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morano, N.C. et al., CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO GPZ6-a.01 FAB. To Be Published
- Release Date
- 2024-07-31
- Peptides
- Envelope glycoprotein gp160: ACE
Envelope glycoprotein gp41: BDF
Antibody GPZ6-a.01 Heavy Chain: GIK
Antibody GPZ6-a.01 Light Chain: HJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
NE
OB
BD
HF
IG
QI
PK
RH
TJ
SL
U
SMTL ID : 8tjs.1
CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO GPZ6-a.01 FAB
Envelope glycoprotein gp160
Toggle Identical (ACE)Envelope glycoprotein gp41
Toggle Identical (BDF)Antibody GPZ6-a.01 Heavy Chain
Toggle Identical (GIK)Antibody GPZ6-a.01 Light Chain
Toggle Identical (HJL)Related Entries With Identical Sequence
4tvp.1 | 4zmj.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 | 6mu7.1 | 6mu8.1 more...less...6nf2.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mxe.1 | 7pc2.1 | 7rai.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8jtd.1 | 8jtm.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8sw3.1 | 8sw4.1 | 8tjr.1 | 8tkc.1 | 8tl2.1 | 8tl3.1 | 8tl4.1 | 8tl5.1 | 8tng.1 | 8tnh.1 | 8tni.1 | 8tnu.1 | 8to7.1 | 8top.1 | 8tq1.1 | 8ttw.1